लोड हो रहा है...
Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature
Atezolizumab is a monoclonal antibody that targets programmed death ligand-1. Treatments with this drug may cause immune-related adverse events by creating an exaggerated inflammatory response. The most common side effects are fatigue, rash, and gastrointestinal symptoms. Cases of central nervous sy...
में बचाया:
| में प्रकाशित: | SAGE Open Med Case Rep |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SAGE Publications
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6088478/ https://ncbi.nlm.nih.gov/pubmed/30116528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X18792422 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|